search
Back to results

Effectiveness of an E-health Intervention in Patients With Obstructive Sleep Apnoea

Primary Purpose

Obstructive Sleep Apnea

Status
Not yet recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Patient education
Sponsored by
Universitat de Lleida
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obstructive Sleep Apnea focused on measuring obstructive sleep apnoea, eHealth tools, patient education, blood pressure, therapeutic exercise

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Moderate OSA (apnoea-hypoapnoea index (AHI)) of 15-30
  • Hypertension diagnosed by 24h-ABPM
  • Men and women aged ≥ 18 years
  • Spanish and/or Catalan can be read, written, and spoken
  • Currently residing in Lleida (Spain)
  • Own or have access to mobile phone (Android and IOS)

Exclusion Criteria:

  • Previous diagnosis of OSA / use of CPAP
  • Pregnancy
  • Body mass index (BMI) below 17
  • Subjects undergoing bariatric intervention or on the waiting list for it
  • Not being able to fill out questionnaires
  • Incapacity to handle technology

Sites / Locations

  • Biomedical Research Institure of Lleida

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental group

Control group

Arm Description

A pilot study will be conducted for 2 months with a sample of 10 participants, in order to gather initial data to test the algorithm from the eHealth tool. During the QUAN phase the algorithm will provide individualized feedback and responses to the patients based on their different variables analyzed in real-time by the wrist receiver device: cardiovascular parameters, sleep quality and structure of sleep, physical activity, oxygen saturation. The eHealth tool will contain all the educational materials developed by the researchers of the study. Depending on the information received from the electronic wrist device the eHealth tool will make recommendations of educational topics as hygienic-dietary measures, sleep related habits, or physical activity. The information provided in this regard will be dependent upon the subjects' knowledge gaps/beliefs identified in the QUAL phase and the parameters measures by the electronic wrist device in each subject.

In the control group, the participants will be provided with the same electronic wrist device and access to the eHeatlh tool as the experimental group. However, the electronic wrist device will not provide feedback based on the parameters of each individual. The information provided by the eHealth tool will be general information from the sleep unit of the Arnau de Vilanova - Santa María Hospital instead of the materials developed from the QUAL phase.

Outcomes

Primary Outcome Measures

Blood pressure
Blood pressure: Blood pressure changes after 3 months of intervention, measured with a holter blood pressure recorder (Spacelabs 90217A, Hertford: UK).

Secondary Outcome Measures

Polysgraphy
Twe will use respiratory polygraphy (Embletta, ResMed, Bella Vista, NSW, Australia) to assess the AHI, oxygen desaturation index (ODI, >4%), minimum and mean oxygen saturation (SaO2), the average duration of events and percentage of time with SaO2 <90%.
The Pittsburgh Sleep Quality Inventory (PSQI)
) is a 19-item list of items used to measure sleep quality and disturbances over the past month. As part of the PSQI, various sleep characteristics are measured, including sleep latency (i.e., the amount of time taken to fall asleep). On a scale of 0 to 3, each item is scored (0 = not during the past month; 1 = less than once a week; 2 = once or twice a week; and 3 = three or more times a week) (49). These scores are summed to generate an overall score. The higher the scores, the lower the quality of sleep. A score of more than five indicates poor sleep quality. With an alpha value of 0.83, the PSQI has demonstrated reliability in its internal consistency
Daytime sleepiness assessment
Subjective sleepiness will be assessed using the "Epworth Sleepiness Scale (ESS)" validated in Spanish. This is a questionnaire that contains eight items that indicate the probability of falling asleep during activities of daily living, ranging from 0 (never) to 3 (high probability). Normal values will be established between 2 and 10, with values greater than 10 indicating daytime sleepiness
Six-minute walk test (6MWT)
The 6MWT test evaluates the respiratory, cardiovascular, metabolic, musculoskeletal, and sensorineural responses to exercise. It is considered a useful tool for assessing the functional capacity of patients with chronic respiratory and/or cardiovascular diseases and is used to assess the submaximal level of functional performance at a similar level required for daily physical activities (55). 6MWT measures the maximum distance an individual is able to walk as fast as possible (not run) using their usual walking aids if any, and take their regular medications before the test, in 6 minutes. The patients can rest is allowed as required but the time is not stopped. The 6MWT is normally carried out in a corridor of 30 meters in length, on a hard and flat surface, and preferably indoors
Empowerment and motivation for change
The Spanish version of the Health Empowerment Scale will be used to measure empowerment, while motivation will be measured using the Self-Efficacy Scale for Physical Activity
Health-related quality of life
This will be assessed using the EuroQol-5D (EQ-5D) questionnaire in its valid Spanish version
Anthropometry measurement 1
Body mass index (BMI) (kg / m 2). In order to calculate BMI, Weight (kg) and height (m) will be measured using a scale and a standard stadiometer.
Anthropometry measurements 2
Waist-to-hip ratio. The waist, and hip circumferences, measured in triplicate and averaged, will be taken into consideration.
Adherence to the program/treatment
Scale of adherence and number of entries to the telephone application.
Cost-benefit
Comparison through the final costs of the current project and the studied costs of conservative treatment according to the research by Tarraubella et al. (2018)

Full Information

First Posted
January 26, 2022
Last Updated
June 15, 2023
Sponsor
Universitat de Lleida
Collaborators
Institut de Recerca Biomèdica de Lleida, Horizon 2020 - European Commission
search

1. Study Identification

Unique Protocol Identification Number
NCT05380726
Brief Title
Effectiveness of an E-health Intervention in Patients With Obstructive Sleep Apnoea
Official Title
Effectiveness of an E-health Intervention on Blood Pressure, Sleep Quality and Physical Activity in Patients With Obstructive Sleep Apnoea: A Sequential Exploratory Mixed-method Research Protocol With a Realist Evaluation Approach
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 1, 2023 (Anticipated)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
December 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitat de Lleida
Collaborators
Institut de Recerca Biomèdica de Lleida, Horizon 2020 - European Commission

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Obstructive sleep apnoea is a highly burdensome condition that not only impairs function but also confers a risk of cardiovascular disease. This is particularly evident among those who are poorly compliant with continuous positive airway pressure ventilation therapy. In the management of a chronic and frequent pathology such as OSA, it is necessary to have personalized programs that implement new technology-based tools to improve the comprehensive management of the patient in order to reduce the morbidity associated with this disease.
Detailed Description
Objectives: The purpose of this study is to evaluate the effectiveness of eHealth tools in managing obstructive sleep apnoea pathophysiological consequences and how they impact the quality of life after 3 months of intervention in adults.Qual: To identify OSA patients' beliefs concerning their condition and its treatment. Connection: To construct the information resources that the mobile application will offer using the QUAL results. Quan: Objective sleep parameters, Subjective sleep quality , Daytime sleepiness Physical activity habits, Quality of life related to health, Self-efficacy and empowerment, Anthropometry, Adherence to the program/treatment, Cost / benefit. Design: Mixed-method sequential exploratory design with realist evaluation approach. Population and sample: Patients referred to the sleep unit of the Arnau de Vilanova - Santa María Hospital for a suspected diagnosis of obstructive sleep apnoea. For the qualitative phase, the subjects will be contacted and invited to participate in a semi-structured personal interview related to the gaps and knowledge needs that these types of patients have about the pathology itself and its management. The quantitative phase will be a randomized controlled trial. Subjects will be randomly assigned using a simple random technique. The experimental group will receive an eHealth intervention through an electronic wristband device and access to the eHealth tool (phone application) that will offer specific recommendations on health, physical activity and hygienic-dietary advice. All these recommendations will be based on the information obtained in the qualitative phase and the parameters mesured by the electronic wristband device in real time. Those in the control group will receive the same electronic wristband device and the same access to the ehealth tool, but the information received will be based on the general hygienic-dietary measures that the sleep unit provides to all patients. This research belongs to Moore4Medical project. It has received funding within the Electronic Components and Systems for European Leadership Joint Undertaking (ECSEL JU) in collaboration with the European Union's H2020 Framework Programme (H2020/2014-2020) and National Authorities, under grant agreement H2020-ECSEL-2019-IA-876190.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea
Keywords
obstructive sleep apnoea, eHealth tools, patient education, blood pressure, therapeutic exercise

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
We will carry out a mixed-method exploratory sequential investigation with a realistic evaluation approach. The use of this mixed methodology allows us to use the strengths of the qualitative and quantitative phases while reducing their weaknesses. Specifically, the sequential exploratory design includes an initial qualitative phase followed by a quantitative phase, with the aim of developing an educational tool. In this project it is proposed that both phases should have the same relevance (QUAL-QUAN) for the development of the educational tool and the development of the study should be carried out in three stages. During all phases of the project, the realistic evaluation approach will be taken into account, especially after the intervention, carrying out different semi-structured interviews and focus groups to redefine the cycle and optimize future research.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
The study will be triple-blind since, due to its nature (intervention using an eHealth tool), it will be possible to blind both the participants, researchers and statisticians. All the subjects (experimental and control) will receive the same electronic wrist device and eHealth tool. While experimental group receive specific information related to the parameters assessed in real time by the wrist device, the control group will receive general information about obstructive sleep apnoea.
Allocation
Randomized
Enrollment
260 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group
Arm Type
Experimental
Arm Description
A pilot study will be conducted for 2 months with a sample of 10 participants, in order to gather initial data to test the algorithm from the eHealth tool. During the QUAN phase the algorithm will provide individualized feedback and responses to the patients based on their different variables analyzed in real-time by the wrist receiver device: cardiovascular parameters, sleep quality and structure of sleep, physical activity, oxygen saturation. The eHealth tool will contain all the educational materials developed by the researchers of the study. Depending on the information received from the electronic wrist device the eHealth tool will make recommendations of educational topics as hygienic-dietary measures, sleep related habits, or physical activity. The information provided in this regard will be dependent upon the subjects' knowledge gaps/beliefs identified in the QUAL phase and the parameters measures by the electronic wrist device in each subject.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
In the control group, the participants will be provided with the same electronic wrist device and access to the eHeatlh tool as the experimental group. However, the electronic wrist device will not provide feedback based on the parameters of each individual. The information provided by the eHealth tool will be general information from the sleep unit of the Arnau de Vilanova - Santa María Hospital instead of the materials developed from the QUAL phase.
Intervention Type
Behavioral
Intervention Name(s)
Patient education
Other Intervention Name(s)
hygienic-dietary measures, sleep related habits, physical activity
Intervention Description
The intervention received will be a specific patient education for each subject depending on the parameters assessed by the electronic wrist device in real-time. The recommendation are related to different educational topics as hygienic-dietary measures and sleep related habits, or physical activity.
Primary Outcome Measure Information:
Title
Blood pressure
Description
Blood pressure: Blood pressure changes after 3 months of intervention, measured with a holter blood pressure recorder (Spacelabs 90217A, Hertford: UK).
Time Frame
Pre-post (after 3 months of intervention)
Secondary Outcome Measure Information:
Title
Polysgraphy
Description
Twe will use respiratory polygraphy (Embletta, ResMed, Bella Vista, NSW, Australia) to assess the AHI, oxygen desaturation index (ODI, >4%), minimum and mean oxygen saturation (SaO2), the average duration of events and percentage of time with SaO2 <90%.
Time Frame
Pre-post (after 3 months of intervention)
Title
The Pittsburgh Sleep Quality Inventory (PSQI)
Description
) is a 19-item list of items used to measure sleep quality and disturbances over the past month. As part of the PSQI, various sleep characteristics are measured, including sleep latency (i.e., the amount of time taken to fall asleep). On a scale of 0 to 3, each item is scored (0 = not during the past month; 1 = less than once a week; 2 = once or twice a week; and 3 = three or more times a week) (49). These scores are summed to generate an overall score. The higher the scores, the lower the quality of sleep. A score of more than five indicates poor sleep quality. With an alpha value of 0.83, the PSQI has demonstrated reliability in its internal consistency
Time Frame
Pre-post (after 3 months of intervention)
Title
Daytime sleepiness assessment
Description
Subjective sleepiness will be assessed using the "Epworth Sleepiness Scale (ESS)" validated in Spanish. This is a questionnaire that contains eight items that indicate the probability of falling asleep during activities of daily living, ranging from 0 (never) to 3 (high probability). Normal values will be established between 2 and 10, with values greater than 10 indicating daytime sleepiness
Time Frame
Pre-post (after 3 months of intervention)
Title
Six-minute walk test (6MWT)
Description
The 6MWT test evaluates the respiratory, cardiovascular, metabolic, musculoskeletal, and sensorineural responses to exercise. It is considered a useful tool for assessing the functional capacity of patients with chronic respiratory and/or cardiovascular diseases and is used to assess the submaximal level of functional performance at a similar level required for daily physical activities (55). 6MWT measures the maximum distance an individual is able to walk as fast as possible (not run) using their usual walking aids if any, and take their regular medications before the test, in 6 minutes. The patients can rest is allowed as required but the time is not stopped. The 6MWT is normally carried out in a corridor of 30 meters in length, on a hard and flat surface, and preferably indoors
Time Frame
Pre-post (after 3 months of intervention)
Title
Empowerment and motivation for change
Description
The Spanish version of the Health Empowerment Scale will be used to measure empowerment, while motivation will be measured using the Self-Efficacy Scale for Physical Activity
Time Frame
Pre-post (after 3 months of intervention)
Title
Health-related quality of life
Description
This will be assessed using the EuroQol-5D (EQ-5D) questionnaire in its valid Spanish version
Time Frame
Pre-post (after 3 months of intervention)
Title
Anthropometry measurement 1
Description
Body mass index (BMI) (kg / m 2). In order to calculate BMI, Weight (kg) and height (m) will be measured using a scale and a standard stadiometer.
Time Frame
Pre-post (after 3 months of intervention)
Title
Anthropometry measurements 2
Description
Waist-to-hip ratio. The waist, and hip circumferences, measured in triplicate and averaged, will be taken into consideration.
Time Frame
Pre-post (after 3 months of intervention)
Title
Adherence to the program/treatment
Description
Scale of adherence and number of entries to the telephone application.
Time Frame
Post intervention (after 3 months)
Title
Cost-benefit
Description
Comparison through the final costs of the current project and the studied costs of conservative treatment according to the research by Tarraubella et al. (2018)
Time Frame
Post intervention (after 3 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Moderate OSA (apnoea-hypoapnoea index (AHI)) of 15-30 Hypertension diagnosed by 24h-ABPM Men and women aged ≥ 18 years Spanish and/or Catalan can be read, written, and spoken Currently residing in Lleida (Spain) Own or have access to mobile phone (Android and IOS) Exclusion Criteria: Previous diagnosis of OSA / use of CPAP Pregnancy Body mass index (BMI) below 17 Subjects undergoing bariatric intervention or on the waiting list for it Not being able to fill out questionnaires Incapacity to handle technology
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Oriol o Martínez-Navarro
Phone
619562618
Ext
+34
Email
omartinez@irblleida.cat
First Name & Middle Initial & Last Name or Official Title & Degree
Fran Valenzuela-Pascual
Email
fran.valenzuela@udl.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fran Valenzuela-Pascual, PhD
Organizational Affiliation
Biomedical Research Institute of Lleida
Official's Role
Principal Investigator
Facility Information:
Facility Name
Biomedical Research Institure of Lleida
City
Lleida
ZIP/Postal Code
25198
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oriol Martínez-Navarro
Phone
619562618
Ext
+34
Email
omartinez@irblleida.cat
First Name & Middle Initial & Last Name & Degree
Fran Valenzuela-Pascual
Email
fran.valenzuela@udl.cat
First Name & Middle Initial & Last Name & Degree
Fran Valenzuela-Pascual, PhD
First Name & Middle Initial & Last Name & Degree
Manuel Sánchez de la Torre, PhD
First Name & Middle Initial & Last Name & Degree
Esther Rubinat Arnaldo, PhD
First Name & Middle Initial & Last Name & Degree
Joan Blanco Blanco, PhD
First Name & Middle Initial & Last Name & Degree
María Masbernat-Almenara, PhD
First Name & Middle Initial & Last Name & Degree
Francesc Rubí Carnacea, PhD
First Name & Middle Initial & Last Name & Degree
Blanca Manuel Martí
First Name & Middle Initial & Last Name & Degree
Rabee Adel
First Name & Middle Initial & Last Name & Degree
Xisco Verdejo Amengual
First Name & Middle Initial & Last Name & Degree
Oriol Martínez-Navarro
First Name & Middle Initial & Last Name & Degree
Ferran Barbé Illa, PhD
First Name & Middle Initial & Last Name & Degree
Gerard Torres Cortada, PhD
First Name & Middle Initial & Last Name & Degree
Jordi de Batlle Garcia, PhD
First Name & Middle Initial & Last Name & Degree
Jessica Gonzalez Gutierrez

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of an E-health Intervention in Patients With Obstructive Sleep Apnoea

We'll reach out to this number within 24 hrs